cetus corp. said_0 the government of spain approved the marketing of its proleukin interleukin-2 drug 0 to treat kidney cancer . the biotechnology concern said_0 spanish authorities must still clear the price for the treatment , but that it_expects to receive such approval by year end . four other_countries in europe have approved proleukin in recent_months . cetus is currently trying_to obtain federal regulatory clearance for u.s. distribution .